Relaxo Footwears Stock Rallies 13% as Q4 Profit Jumps 20% on Core Volume Recovery

Synopsis: Posting its strongest quarterly performance of FY26, India’s largest non-leather footwear manufacturer reported a 20.4 percent jump in Q4 PBT and a 16.5 percent EBITDA margin its best in five quarters even as the full year remained challenged by a 3.1 percent revenue decline and subdued volume offtake. The Q4 recovery is real, but FY26 as a whole tells a story of stagnation that investors will need to weigh against the company’s debt-free balance sheet and steadily improving margin trajectory.

Shares of a leading Indian footwear manufacturer came into focus after the company filed its investor presentation for Q4 and full-year FY26 results with BSE on May 28, 2026. The quarterly numbers showed a sharp recovery from a weak H1 particularly on profitability  though the annual picture remained under pressure.

With a market capitalization of Rs. 8,563.49 crore, the shares of Relaxo Footwears were trading at Rs. 344  per share, up 13.91 percent from its previous close of Rs.302.. It is trading at a P/E of 41.94.

Q4 FY26 Performance Update

The quarter to March 2026 was the company’s best in five periods. Revenue grew 8.1 percent year-on-year to Rs. 751 crore, while EBITDA rose 10.7 percent to Rs. 124 crore  with margin expanding 39 basis points to 16.5 percent. PBT came in at Rs. 90.8 crore, up 20.5 percent, and PAT at Rs. 67.7 crore, up 20.4 percent. Volume for the quarter reached 5.0 crore pairs, a meaningful pickup from the 4.0 crore pairs shipped in Q3 FY26.

What makes the Q4 numbers read well is the sequential improvement in operating leverage. EBITDA in Q3 FY26 was Rs. 69 crore at a 10.4 percent margin; the jump to Rs. 124 crore at 16.5 percent in Q4 partly reflects seasonal demand normalisation, but the scale of recovery also suggests the company’s cost base is more flexible than the H1 weakness implied. Average realisation per pair dipped to Rs. 150 from Rs. 153 a year ago, meaning the revenue growth was volume-led rather than price-led, a relevant distinction for margin sustainability going forward.

FY26 Annual Picture: Recovery Incomplete

The full-year story is less flattering. Revenue declined 3.1 percent to Rs. 2,702 crore from Rs. 2,790 crore in FY25, and volume fell from 17.8 crore to 17.5 crore pairs. EBITDA slipped marginally to Rs. 374 crore (margin 13.8 percent, up 15 basis points). PAT grew 5.3 percent to Rs. 179 crore, the benefit coming more from lower effective costs than from top-line expansion.

Looked at FY24, the trajectory is sobering: revenue has contracted from Rs. 2,914 crore, and PAT from Rs. 200 crore. The company’s five-year compounded sales growth stands at roughly 3 percent and its three-year profit growth is negative. These are not crisis numbers for a debt-free manufacturer with Rs. 374 crore EBITDA, but they do explain why the stock has de-rated sharply over the past three years.

The balance sheet, at least, provides comfort. The company held a net cash position of Rs. 206 crore at March 2026. Net worth grew to Rs. 2,206 crore. Capex for the year was Rs. 139 crore  moderate relative to the asset base  and cash generated from operations came in at Rs. 415 crore, up from Rs. 302 crore a year ago. ROCE held steady at 12.1 percent. For a consumer goods manufacturer in a weak demand cycle, this profile of capital discipline and positive free cash flow is not trivial.

Revenue Mix and Brand Dynamics

In terms of brand composition, Sparx contributed 41 percent of revenue but only 16 percent of volume  confirming its role as the premium driver. Hawai, at 45 percent of volume but 23 percent of revenue, anchors the mass-market segment. Flite sits in the middle. The mismatch between volume and revenue share in Sparx versus Hawai reflects the fundamental tension in the company’s portfolio: the mass segment moves units but compresses blended realisation, while Sparx adds per-pair value but is not yet large enough in volume terms to shift overall averages.

General trade accounts for 74 percent of channel revenue, with the company reaching over 70,000 retailers through around 630 active distributors. The export presence spans 37 countries, supported by an overseas office in Dubai.

Business Overview

Relaxo Footwears Limited is India’s largest non-leather footwear manufacturer. The company operates nine manufacturing facilities with a capacity of approximately 10.5 lakh pairs per day, and markets products under the Relaxo, Sparx, Flite, and Bahamas brands.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Relaxo Footwears Stock Rallies 13% as Q4 Profit Jumps 20% on Core Volume Recovery appeared first on Trade Brains.